Effect of institutional volume and academic status on outcomes of coronary interventions: The IMPACT-II experience

American Heart Journal

Volumn 138, Issue 5 I, 1999, Pages 976-982

  Gilchrist, I C ^a   Gardner, L H ^a   Muhlestein, J B ^a   Arnold, A M ^a   Lincoff, A M ^a   Califf, R M ^a   Tcheng, J E ^a   Topol, E J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO;

ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; HEART DEATH; HEART INFARCTION; HEART SURGERY; HOSPITAL ADMISSION; MODEL; PRIORITY JOURNAL; TEACHING HOSPITAL; TREATMENT OUTCOME; UNITED STATES;

EID: 0032693813     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70026-8     Document Type: Article

References (20)

1. Ritchie JL, Phillips KA, Luft HS. Coronary angioplasty statewide experience in California. Circulation 1993;88:2735-43.
2. Phillips KA, Luft HS, Ritchie JL. The association of hospital volumes of percutaneous transluminal coronary angioplasty with adverse outcomes, length of stay, and charges in California. Med Care 1995;33:502-14.
3. Jollis JG, Peterson ED, DeLong ER, Mark DB, Collins SR, Muhlbaier LH, et al. The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and shortterm mortality. N Engl J Med 1994;331:1625-9.
4. Jollis JG, Peterson ED, Nelson CL, Stafford JA, DeLong ER, Muhlbaier LH, et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation 1997;95:2485-91.
5. Kimmel SE, Berlin JA, Laskey, WK. The relationship between coronary angioplasty procedure volume and major complications. JAMA 1995;274:1137-42.
6. Hannan EL, Racz M, Ryan TJ, McCallister BD, Johnson LW, Arani DT, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA 1997;279:892-8.
7. Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures. ACC Clinical Competence Statement. J Am Coll Cardiol 1998;31:722-43.
8. Kimmel SE, Berlin JA, Strom BL, Laskey WK, for the Registry Committee of the Society for Cardiac Angiography and Interventions. Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. J Am Coll Cardiol 1995;26:931-8.
9. Roubin GS, Douglas JS Jr, King SB III. Percutaneous coronary angioplasty: influence of operator experience on results. Am J Cardiol 1986;57:873-4.
10. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB III, McCallister BD, et al. Guidelines for percutaneous transluminal coronary angioplasty. Circulation 1993;88:2987-3007.
11. IMPACT-II Investigators. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention. Lancet 1997;349:1422-8.
12. Abdelmeguid AE, Ellis SG, Sapp SK, Whitlow PL, Topol EJ. Defining the appropriate threshold of creatine kinase elevation after percutaneous interventions. Am Heart J 1996;131:1097-105.
13. Waksman R, Scott NA, Douglas JS, Mays R, Yee-Petersen J, King SB. Distal embolization is common after directional atherectomy in coronary arteries and vein grafts [abstract]. Circulation 1993;88(Suppl I):I-299.
14. Ellis SG, Weintraub W, Holmes D, Shaw R, Block PC, King SP III. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volume. Circulation 1997;96:2479-84.
15. Detre K, Holubkov R, Kelsey S, Cowley M, Kent K, Williams D, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Registry. N Engl J Med 1988;318:265-70.
16. Ellis SG, Cowley MJ, Whitlow PJ, Vandormael M, Lincoff AM, DiSciascio G, et al. Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improvement in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group. J Am Coll Cardiol 1995;25:1137-42.
17. Altmann DB, Racz M, Battleman DS, Bergman G, Spokojny A, Hannan EL, et al. Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients. Am Heart J 1996;132:503-7.
18. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hoffling B, Simonton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary disease. N Engl J Med 1993;329:221-7.
19. Rosenthal GE, Harper DL, Quinn LM, Cooper GS. Severity-adjusted mortality and length of stay in teaching and non-teaching hospitals. JAMA 1997;278:485-90.
20. Topol EJ, Ellis SG, Cosgrove DM, Bates ER, Muller DWM, Schork NJ, et al. Analysis of coronary angioplasty practice in the United States with an insurance-claims data base. Circulation 1993;87:1489-97.